Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Stopped Decision of independent monitoring committee after interim analysis: Risk of failure significantly higher in ceftazidime group.

Conditions

• Cirrhosis
• Ascites
• Nosocomial Spontaneous Bacterial Peritonitis

Interventions

• DRUG: Daptomycin + Meropenem
• DRUG: Ceftazidime

Sponsor

University of Padova